Since MALAT1 is expressed in various cell types, and affects the function of CD8+ and CD4+ T cells (74, 171), it remains to be seen whether SELs or siRNAs that target MALAT1 are effective in inhibiting the growth of different tumor types. This evidence concerns the gene CD8A and neoplasm.